Success Story: NIW Approval in 53 Days for a Bioinformatics Researcher Advancing Cancer and Aging Research
Client’s Testimonial:
"I have a background in bioinformatics, and I was quite worried that my citation count was too low, but my case was ultimately approved. They are very professional and know how to highlight your strengths. They revise the materials based on your feedback until you’re satisfied. They also seem to have a clear sense of whether a case is likely to be approved and avoid unnecessary content. Everything that needed to be included in the petition letter was covered, especially the recommendation letters—they were written extremely well, and I made almost no changes. I’m very grateful to them and would be happy to work with them again in the future."
On April 24th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
State of Residence at the Time of Filing: Texas
Approval Notice Date: April 24th, 2026
Processing Time: 1 month, 22 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group is pleased to share the I-140 NIW approval of a bioinformatics researcher whose work sits at the intersection of biostatistics, machine learning, and biomedical discovery. Filed with direct Premium Processing, the petition was approved in just 53 days.
The Research Vision
The client’s proposed endeavor focused on developing computational tools and applying statistical methods and machine learning to extract meaningful biological insight from complex datasets. Specifically, the client aimed to advance research on aging-related diseases and cancer, identify potential drug targets, integrate and interpret multi-omics data, and use pan-cancer omics and single-cell RNA-sequencing data to study epithelial-mesenchymal transition in tumorigenesis.
Rather than framing the case around general biomedical interest, the petition explained how the client’s work helps solve a practical research bottleneck. Large public and institutional omics datasets are valuable only when researchers can analyze, compare, and interpret them effectively. The client’s computational tools helped turn these complex datasets into usable frameworks for studying disease mechanisms, cancer progression, cellular senescence, and potential therapeutic targets.
A Record Built on Independent Validation
To show that the client was well-positioned to advance the endeavor, the petition highlighted 7 peer-reviewed journal articles, including 2 first-authored articles and 1 co-first-authored article, as well as 1 first-authored preprint. These publications were presented as evidence that the client had already produced accepted, field-relevant methods and findings in bioinformatics.
The petition also addressed the client’s 32 citations by explaining how citations reflected early independent use of the client’s work. Other researchers relied on the client’s findings and tools in studies involving transcriptomic regulation, cellular senescence, cancer biology, spatial transcriptomics, deconvolution methods, and essential gene prediction. This helped show that the client’s contributions were not isolated outputs, but resources and findings that others could build upon.
Equally important, the client had completed at least 24 peer reviews. We used this evidence to show that the client’s expertise was recognized by the broader research community, since peer-review invitations reflect trust in a researcher’s ability to assess technical quality, methodology, and scientific significance.
Funding and Expert Support
The petition further strengthened the national-importance argument by documenting major funding support connected to the client’s research, including support from the National Institutes of Health and the National Science Foundation. This evidence helped link the client’s work to broader U.S. priorities in biomedical research, disease prevention, precision medicine, and health-related data science.
Four recommendation letters were also included to explain the client’s contributions from the perspective of field experts. These letters supported the petition’s argument that the client’s work provided useful computational approaches for interpreting omics data, studying aging and cancer mechanisms, and improving the search for disease-relevant genes and therapeutic targets. As one expert reviewer summarized:
“In essence, [Client] empowers the global research community to implement more sophisticated, biologically meaningful computational solutions while promoting scientific competitiveness through enhanced transcriptomic analysis and precision oncology data mining capabilities.”
The Approval
We congratulate our client on receiving I-140 NIW approval in 53 days without an RFE, and we look forward to seeing the continued impact of her bioinformatics research on aging-related disease and cancer studies in the United States.